bisantrene has been researched along with Melanoma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Marco, C; Folini, M; Palumbo, M; Pivetta, C; Sissi, C; Zaffaroni, N; Zagotto, G | 1 |
Alberts, DS; Mackel, C; Pocelinko, R; Salmon, SE | 1 |
Angier, RB; Citarella, RV; Durr, FE; Forbes, M; Murdock, KC; Wallace, RE | 1 |
Annable, T; Arceci, RJ; Collins, KI; Durr, FE; Greenberger, LM; Ho, JP; Ritke, MK; Slovak, ML; Yalowich, JC; Zhang, XP | 1 |
Blough, RR; Johnson, CM; Kilton, LJ; Muntean, B; Stiff, PJ; Sweet, D | 1 |
Alberts, DS; Cowan, JD; Epstein, RB; Fletcher, WS; Green, SJ; Guy, JT; Mason-Liddil, N; Neilan, B | 1 |
Alberts, DS; Mackel, C; Meyskens, FL | 1 |
Bishop, J; Coates, AS; Mann, GJ; Raghavan, D | 1 |
Citarella, RV; Durr, FE; McWilliams, W; Nicolau, G; Wu, WH | 1 |
1 trial(s) available for bisantrene and Melanoma
Article | Year |
---|---|
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms | 1982 |
8 other study(ies) available for bisantrene and Melanoma
Article | Year |
---|---|
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
Topics: Anthracenes; Antibiotics, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; G-Quadruplexes; Humans; Inhibitory Concentration 50; Isomerism; Melanoma; Molecular Structure; Nucleic Acid Denaturation; Osteosarcoma; Structure-Activity Relationship; Taq Polymerase; Telomerase; Telomere | 2010 |
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Topics: Animals; Anthracenes; Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Fluorouracil; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Plasmacytoma | 1982 |
P-glycoprotein mediates profound resistance to bisantrene.
Topics: Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chromosome Banding; Chromosomes, Human; Clone Cells; Colonic Neoplasms; DNA Primers; Drug Resistance, Multiple; Humans; In Situ Hybridization, Fluorescence; KB Cells; Melanoma; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1994 |
Phase II trial of Bisantrene for metastatic melanoma: an Illinois cancer council study.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Illinois; Infusions, Intravenous; Leukopenia; Male; Melanoma; Middle Aged; Phlebitis; Survival Rate | 1991 |
Phase II evaluation of bisantrene hydrochloride in refractory malignant melanoma. A Southwest Oncology Group Study.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged | 1987 |
Phase II trial of bisantrene in patients with metastatic melanoma.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis | 1986 |
Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene.
Topics: Aminoacridines; Amsacrine; Anthracenes; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Mitoxantrone; Phlebitis; Skin Neoplasms | 1986 |
Tissue deposition of bisantrene in B16 melanoma tumor-bearing mice.
Topics: Animals; Anthracenes; Antibiotics, Antineoplastic; Carbon Radioisotopes; Cell Line; Male; Melanoma; Mice; Mice, Inbred Strains; Tissue Distribution | 1986 |